AC Immune SA at Jefferies London Healthcare Conference Transcript
Good morning. I think this is the first presentation in this track, so, I welcome you all to the Jefferies 2022 Healthcare Conference in London. Because you don't know me, my name is Peter Welford, I have AC Immune, today, the CEO, Andrea Pfeifer.
Andrea's going to walk through a few slides, and give you a background as an intro to the company, and then, we'll go to Q&A. As usual, if anyone in the audience has any questions, please raise your hand. We have dozen who would love some participation, of now -- I'll just continue in the usual vein.
And with that, over to Andrea, and thank you very much.
Good morning. Thank you for joining. I'm happy to speak to you about AC Immune company, pioneering precision medicine in neurodegenerative diseases.
Today, I will give at the beginning, just a short overview of our company, followed by an update on the pipeline, and our upcoming milestones. So -- What you will see later, AC Immune
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |